Literature DB >> 2167552

Coexpression of the human papillomavirus type 16 E4 and L1 open reading frames in early cervical neoplasia.

C P Crum1, S Barber, M Symbula, K Snyder, A M Saleh, J K Roche.   

Abstract

Although the E4 open reading frame (ORF) of human papillomaviruses (HPV) encodes an abundant protein in cutaneous warts, the location and extent of HPV E4 expression in genital precancers, specifically those associated with HPV-16, has not been described. Expression plasmids (pATH) containing segments of the HPV-16 E4 (3401-3620) and L1 (6151-6792) open reading frames (ORFs) were induced and expressed in bacteria and the resulting fusion proteins were used to elicit antisera in rabbits. Antisera reacting to the E4 and L1 components of the fusion proteins were used to screen biopsies from 150 cervical precancers (cervical intraepithelial neoplasia) and condylomata. Six biopsies exhibiting specific immunostaining with the anti-E4 sera. Staining was cytoplasmic, and occurred virtually always in foci containing immunostaining for L1 proteins. Moreover, analysis of these 6 cases and 22 others for HPV-16 RNA by RNA-RNA in situ hybridization demonstrated a similar correlation between E4 immunostaining and the presence of abundant transcripts specific to HPV-16. These data are consistent with the hypothesis that expression of the HPV-16 E4 ORF is dependent upon viral replication and epithelial differentiation, similar to L1 expression, and that the E4 epitopes identified by the rabbit antisera may be unique to HPV-16 relative to other common cervical papillomaviruses.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167552     DOI: 10.1016/0042-6822(90)90399-c

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  16 in total

1.  Biologic properties and nucleotide sequence analysis of human papillomavirus type 51.

Authors:  O Lungu; C P Crum; S Silverstein
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Characterization of in vivo expression of the human papillomavirus type 16 E4 protein in cervical biopsy tissues.

Authors:  J M Palefsky; B Winkler; J P Rabanus; C Clark; S Chan; V Nizet; G K Schoolnik
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  Mutational analysis of human papillomavirus E4 proteins: identification of structural features important in the formation of cytoplasmic E4/cytokeratin networks in epithelial cells.

Authors:  S Roberts; I Ashmole; L J Gibson; S M Rookes; G J Barton; P H Gallimore
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

4.  Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions.

Authors:  F Stubenrauch; A M Colbert; L A Laimins
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Mutational analysis of the human papillomavirus type 16 E1--E4 protein shows that the C terminus is dispensable for keratin cytoskeleton association but is involved in inducing disruption of the keratin filaments.

Authors:  S Roberts; I Ashmole; S M Rookes; P H Gallimore
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  Phosphorylation of the human papillomavirus type 16 E1--E4 protein at T57 by ERK triggers a structural change that enhances keratin binding and protein stability.

Authors:  Qian Wang; Alan Kennedy; Papia Das; Pauline B McIntosh; Steven A Howell; Erin R Isaacson; Steven A Hinz; Clare Davy; John Doorbar
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

Review 7.  Pathobiology of papillomavirus-related cervical diseases: prospects for immunodiagnosis.

Authors:  C P Crum; S Barber; J K Roche
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

8.  Expression pattern and subcellular localization of human papillomavirus minor capsid protein L2.

Authors:  Zhenhua Lin; Anna V Yemelyanova; Ratish Gambhira; Subhashini Jagu; Craig Meyers; Reinhard Kirnbauer; Brigitte M Ronnett; Patti E Gravitt; Richard B S Roden
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

9.  Development of type-specific and cross-reactive serological probes for the minor capsid protein of human papillomavirus type 33.

Authors:  C Volpers; M Sapp; C A Komly; P Richalet-Secordel; R E Streeck
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

10.  Human papillomavirus type 1 E4 proteins differing by their N-terminal ends have distinct cellular localizations when transiently expressed in vitro.

Authors:  C Rogel-Gaillard; F Breitburd; G Orth
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.